Therapeutic KRASG12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers.

Autor: Mugarza, Edurne1, van Maldegem, Febe1, Boumelha, Jesse1, Moore, Christopher1, Rana, Sareena1, Sopena, Miriam Llorian2, East, Philip2, Ambler, Rachel1, Anastasiou, Panayiotis1, Romero-Clavijo, Pablo1, Valand, Karishma1, Cole, Megan1, Molina-Arcas, Miriam1 miriam.molina@crick.ac.uk, Downward, Julian1,3 julian.downward@crick.ac.uk
Zdroj: Science Advances. 7/22/2022, Vol. 8 Issue 29, p1-19. 19p.
Databáze: Academic Search Ultimate